On May 31, 2017, Invacare Corporation (the “Company”) received notice that A. Malachi Mixon, III, the Company’s former chairman and chief executive officer, and his affiliates holding Class B Common Shares of the Company (“Class B Common Shares”) have irrevocably elected to convert all 703,912 of the Class B Common Shares that they collectively hold into Common Shares of the Company (“Common Shares”). In accordance with the Company’s Articles of Incorporation, such Class B Common Shares will convert into Common Shares on a share-for-share basis and entitle the holders thereof to one vote per share on all matters subject to a vote by the Company’s shareholders. Class B Common Shares entitle the holders thereof to 10 votes per share on such matters. Although the Company cannot predict whether or when Mr. Mixon and/or his affiliates may take further action with respect to their Company share holdings, ownership of the Common Shares is relatively concentrated, and the market price could be negatively impacted by sales in a short period of time, or the expectation that such sales were imminent, by any of the holders of significant amounts of the outstanding shares.

Based on the Company’s Common Shares and Class B Common Shares outstanding as of May 30, 2017, after completion of the conversion, the total outstanding voting power of the Company will be reduced from 40,155,366 votes to 33,820,158 votes. After the conversion, 18,357 Class B Common Shares will remain outstanding. The conversion will substantially diminish the significance of the Company’s dual class voting structure, as after completion, the holders of the Common Shares will represent approximately 99.5% of the Company’s total outstanding voting power.

About INVACARE CORPORATION (NYSE:IVC)

Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific. The Company manufactures and distributes three product categories: mobility and seating, lifestyle and respiratory therapy. It provides medical device solutions for congenital (cerebral palsy, muscular dystrophy and spina bifida), acquired (stroke, spinal cord injury, traumatic brain injury, post-acute recovery and pressure ulcers) and degenerative (amyotrophic lateral sclerosis, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly and bariatric) ailments. The Company sells its products to home medical equipment providers with retail and e-commerce channels, residential living operators, distributors and government health services.

INVACARE CORPORATION (NYSE:IVC) Recent Trading Information

INVACARE CORPORATION (NYSE:IVC) closed its last trading session down -0.05 at 14.15 with 149,184 shares trading hands.